Identification of a key determinant of ryanodine receptor type 1 required for activation by 4-chloro-m-cresol

被引:37
作者
Fessenden, JD
Perez, CF
Goth, S
Pessah, IN
Allen, PD
机构
[1] Brigham & Womens Hosp, Dept Anesthesia Res, Boston, MA 02115 USA
[2] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA
关键词
D O I
10.1074/jbc.M303821200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
4-Chloro-m-cresol (4-CmC) is a potent and specific activator of the intracellular Ca2+ release channel, the ryanodine receptor (RyR). We have previously shown that RyR1 expressed in dyspedic 1B5 myotubes is activated by 4-CmC, whereas RyR3 is not (Fessenden, J. D., Wang, Y., Moore, R. A., Chen, S. R. W., Allen, P. D., and Pessah, I. N. (2000) Biophys. J. 79, 2509-2525). To identify region(s) on RyR1 that are responsible for mediating activation by 4-CmC, we expressed RyR1-RyR3 chimeric proteins in dyspedic 1B5 myotubes and then measured 4-CmC-induced increases in intracellular Ca2+. Substitution of the C-terminal third of RyR1 into RyR3 imparted 4-CmC sensitivity to the resulting chimera, thus suggesting that determinants required for activation by 4-CmC are located in this region. We subdivided the C-terminal third of RyR1 into smaller segments and identified two overlapping regions of RyR1 (amino acids 3769-4180 and 4007-4382) that each imparted 4-CmC sensitivity to RyR3. Substitution of the 173 amino acids of RyR1 common to these two chimeras (amino acids 4007-4180) also weakly restored 4-CmC sensitivity in the resulting chimera. To confirm these findings, we created a complementary set of chimeras containing RyR3 substitutions in RyR1. Substitution of the RyR3 C terminus into RyR1 disrupted 4-CmC sensitivity in the resulting chimera. In addition, substitution of the corresponding RyR3 sequence into positions 4007-4180 of RyR1 disrupted 4-CmC sensitivity. Taken together, these results suggest that essential determinants required for activation of RyR1 by 4-CmC reside within a 173-amino acid region between residues 4007 and 4180.
引用
收藏
页码:28727 / 28735
页数:9
相关论文
共 41 条
[1]  
ABRAMSON JJ, 1988, MOL CELL BIOCHEM, V82, P81
[2]   Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor [J].
Avila, G ;
Dirksen, RT .
JOURNAL OF GENERAL PHYSIOLOGY, 2001, 118 (03) :277-290
[3]   A multicenter study of 4-chloro-m-cresol for diagnosing malignant hyperthermia susceptibility [J].
Baur, CP ;
Bellon, L ;
Felleiter, P ;
Fiege, M ;
Fricker, R ;
Glahn, K ;
Heffron, JJA ;
Herrmann-Frank, A ;
Jurkat-Rott, K ;
Klingler, W ;
Lehane, M ;
Ording, H ;
Tegazzin, V ;
Wappler, F ;
Georgieff, M ;
Lehmann-Horn, F .
ANESTHESIA AND ANALGESIA, 2000, 90 (01) :200-205
[4]   BOUND AND DETERMINED - A COMPUTER-PROGRAM FOR MAKING BUFFERS OF DEFINED ION CONCENTRATIONS [J].
BROOKS, SPJ ;
STOREY, KB .
ANALYTICAL BIOCHEMISTRY, 1992, 201 (01) :119-126
[5]  
CALLAWAY C, 1994, J BIOL CHEM, V269, P15876
[6]   Molecular identification of the ryanodine receptor Ca2+ sensor [J].
Chen, SRW ;
Ebisawa, K ;
Li, XL ;
Zhang, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (24) :14675-14678
[7]  
Choisy S, 1999, J PHARMACOL EXP THER, V290, P578
[8]  
Choisy S, 2000, J PHARMACOL EXP THER, V294, P884
[9]   Functional consequences of mutations of conserved, polar amino acids in transmembrane sequences of the Ca2+ release channel (ryanodine receptor) of rabbit skeletal muscle sarcoplasmic reticulum [J].
Du, GG ;
MacLennan, DH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) :31867-31872
[10]   Ca2+ inactivation sites are located in the COOH-terminal quarter of recombinant rabbit skeletal muscle Ca2+ release channels (ryanodine receptors) [J].
Du, GG ;
MacLennan, DH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (37) :26120-26126